Jones Financial Companies Lllp Acquires 9,385 Shares of Colgate-Palmolive Company $CL

Jones Financial Companies Lllp increased its holdings in Colgate-Palmolive Company (NYSE:CL) by 15.5% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 69,904 shares of the company’s stock after buying an additional 9,385 shares during the quarter. Jones Financial Companies Lllp’s holdings in Colgate-Palmolive were worth $5,566,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Westside Investment Management Inc. raised its holdings in shares of Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the last quarter. Copia Wealth Management bought a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC raised its stake in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares during the last quarter. Cloud Capital Management LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter valued at $30,000. Finally, MTM Investment Management LLC bought a new position in shares of Colgate-Palmolive during the 2nd quarter valued at $39,000. Institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

CL opened at $94.48 on Friday. The company has a 50 day simple moving average of $82.13 and a two-hundred day simple moving average of $81.65. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The firm has a market cap of $76.16 billion, a P/E ratio of 36.06, a PEG ratio of 4.29 and a beta of 0.29. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. During the same quarter in the previous year, the company earned $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Jefferies Financial Group upped their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Morgan Stanley boosted their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research note on Monday. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research note on Tuesday, December 9th. Piper Sandler raised their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $94.00 target price on shares of Colgate-Palmolive in a report on Saturday, January 31st. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $94.47.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.